The antimicrobial stewardship program included a team of two infectious disease physicians and three intensive care unit pharmacists, who audited new starts and weekly use of eight antimicrobials. Researchers compared outcomes from one year before and after implementation of the program.
A review of 510 antimicrobial orders showed a majority (63 percent) were appropriate, while the others prompted de-escalation, denial or formal consultation with an infectious disease physician. The antimicrobial stewardship program also led to a 50 percent risk reduction for C. difficile infections; a 13.3 percent decrease in antimicrobial cost per patient-day; a 15.2 percent decrease in the hospital’s antimicrobial budget and 25.4 percent decrease in daily doses of the eight antimicrobials.
The researchers, however, found the antimicrobial stewardship program did not improve 30-day mortality or readmission rates.
Related Articles on Antimicrobial Stewardship:
Antimicrobial Resistance to Common UTI Drug Increases 5-Fold
CDC: State-Level Epidemiology Workforce on the Rise
Antimicrobial Stewardship Program Halved Utilization Costs in 7 Years
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
